Compositions and methods for organ-protective expression and modulation of coding ribonucleic acids
MYPI2025005244A0Undetermined Publication Date: 2021-08-21COMBINED THERAPEUTICS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MYPI2025005244
- Authority / Receiving Office
- MY · MY
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2020-07-31
- Filing Date
- 2021-02-22
- Publication Date
- 2021-08-21
Abstract
Compositions are provided comprising messenger RNA constructs having at least one open reading frame (ORF), wherein the ORF is operatively linked to at least one untranslated region (UTR), wherein the UTR comprises at least one organ protection sequence (OPS), wherein the OPS sequence comprises at least a first, a second and a third micro-RNA (miRNA) target sequence, and wherein each of the at least a first, second and third the miRNA target sequences are optimised to hybridise with a corresponding miRNA sequence. The compositions and molecules provided are useful in therapies such as for the treatment of cancer, in immunotherapies, and in vaccines. [Figure 1]
Need to check novelty before this filing date? Find Prior Art
